Showing results (691-700 of 5,714) with videos related to

Sort By:
Pageof 572
Medical Oncology (Northwood, London, England)|October 22, 2008
Giant cell lung carcinoma in a man with acquired immunodeficiency syndromeTakahide Kodama, Kunihiko Miyazaki, Hiroaki Satoh, et al.
Medical Oncology (Northwood, London, England)|June 17, 2010
S-1-based therapy versus 5-FU-based therapy in advanced gastric cancer: a meta-analysisJiahao Huang, Yunfei Cao, Liucheng Wu, et al.
Medical Oncology (Northwood, London, England)|June 5, 2010
Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphomaHossein Ahmadzadehfar, Margarida Rodrigues, Rasoul Zakavi, et al.
Medical Oncology (Northwood, London, England)|August 30, 2011
CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosisPeng Xu, Xiao-Lan Xu, Qiang Huang, et al.
Medical Oncology (Northwood, London, England)|August 30, 2011
Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of ChinaXiao Wang, Shuai Wang, Yi-wei Lin, et al.
Medical Oncology (Northwood, London, England)|September 28, 2011
Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancersGuzin Gonullu Demirag, Yurdanur Sullu, Idris Yucel
Medical Oncology (Northwood, London, England)|September 28, 2011
Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacitySemra Paydas
Medical Oncology (Northwood, London, England)|August 31, 2011
Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapyLiang Wang, Panpan Liu, Xiaoqin Chen, et al.
Medical Oncology (Northwood, London, England)|May 25, 2011
T-cell receptor gene rearrangement in Epstein-Barr virus infectious mononucleosisL Marbello, M Riva, S Veronese, et al.
Medical Oncology (Northwood, London, England)|June 4, 2011
Role of urokinase plasminogen activator receptor (CD87) as a prognostic marker in acute myeloid leukemiaMaha Atfy, Mohamad Eissa, Hossam E Salah, et al.
Pageof 572